Citadel Advisors
TLSA icon

Citadel Advisors’s Tiziana Life Sciences TLSA Stock Holding History

Citadel Advisors’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-800
Closed -$864 – 15085
2025
Q1 		$864 Buy
+800
New +$782 ﹤0.01% 14206
2021
Q2 		– Sell
-19,300
Closed -$53K – 14437
2021
Q1 		$53K Buy
+19,300
New +$64K ﹤0.01% 12878

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
MAWAG
Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors's TLSA Position: Q2 2026 in Review

Citadel Advisors increased its Tiziana Life Sciences (TLSA) stake by 129% in Q2 2026, buying an estimated $58.7K and bringing the position to 80,222 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #12685.

Citadel Advisors first reported a position in TLSA in Q1 2019 and has held it in 10 quarters since. The position peaked at $314K in Q2 2025. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

  • Citadel Advisors held 80,222 shares of Tiziana Life Sciences worth $103K as of Q2 2026.
  • Citadel Advisors bought 45,128 Tiziana Life Sciences shares in Q2 2026, an estimated $58.7K.
  • Tiziana Life Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12685 holding.
  • Citadel Advisors first reported a position in Tiziana Life Sciences in Q1 2019 and has held it in 10 quarters since.
  • Citadel Advisors's Tiziana Life Sciences position peaked at $314K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.